Bioprinting Solutions for Diabetic Kidney Failure: The Future of Tissue-Engineered Organs
| dc.contributor.author | Amin, Reema | |
| dc.date.accessioned | 2025-06-23T15:16:22Z | |
| dc.date.available | 2025-06-23T15:16:22Z | |
| dc.date.issued | 2025-05 | |
| dc.description.abstract | In this study I determined the feasibility of 3D bioprinting for diabetic kidney failure management, discussing its suitability, economic pros and cons, and practical barriers when moving to a clinical setting with bioprinted kidneys. Insights were generated using a dual method of analysis, which involved a systematic review of literature and direct surveys with diabetic patients, their family members, and medical professionals. The primary objective was to determine whether 3D bioprinting is a viable and acceptable alternative for kidney transplants, primarily to address the scarcity of available organs and to control diabetes associated with kidney complications. Though the participants’ awareness of the bioprinting technology was low, the study identified potential for bioprinted kidneys when these were proven safe and effective. The rate of kidney-related hospitalizationsin survey participants was associated with increased willingness to consider bioprinting for kidney replacement. Analysis of the research and data showed that there are number of significant barriers to widespread implementation averaging safety concerns, excessive cost, unclear regulations and insufficient clinical preparation. However, the entry of superior biomaterials, stem cell-derived organoids, and cost-effective printing technologies is evidence that the technology is advancing fast to practicality. The research shows that bioprinted kidneys are not yet a clinical possibility for kidney replacement but the preparation for the incorporation of bioprinted kidneys in medical practice is developing rapidly. Patients who were afflicted by kidney failure expressed the greatest enthusiasm for this technology, showing the need for personal as well as cost-effective treatments. In creating a readily accessible knowledge data bank, this dissertation advances the scholarly and clinical arguments about kidney bioprinting programs. To promote the incorporation of bioprinted kidneys into day-to-day healthcare, the study recommends increased public education, the development of ethical frameworks, and policy provisions in unethical provision | |
| dc.identifier.uri | https://hdl.handle.net/20.500.14136/236 | |
| dc.title | Bioprinting Solutions for Diabetic Kidney Failure: The Future of Tissue-Engineered Organs | |
| dc.type | Thesis |